Evolent Health SG&A Expense (Quarterly) Insights

Evolent Health Inc (EVH)

25.46 -1.50 (-5.56%) USD | NYSE | May 10, 09:51

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	81.43M
September 30, 2023	96.57M
June 30, 2023	90.39M
March 31, 2023	89.73M
December 31, 2022	82.86M
September 30, 2022	68.52M
June 30, 2022	58.96M
March 31, 2022	58.93M
December 31, 2021	66.92M
September 30, 2021	51.29M
June 30, 2021	42.70M
March 31, 2021	58.59M
December 31, 2020	58.66M
September 30, 2020	52.37M
June 30, 2020	47.30M
March 31, 2020	52.09M
December 31, 2019	-72.77M
September 30, 2019	93.61M
June 30, 2019	103.02M
March 31, 2019	112.60M

Date	Value
December 31, 2018	81.64M
September 30, 2018	76.56M
June 30, 2018	75.83M
March 31, 2018	72.28M
December 31, 2017	55.20M
September 30, 2017	45.83M
June 30, 2017	51.09M
March 31, 2017	53.55M
December 31, 2016	57.59M
September 30, 2016	38.40M
June 30, 2016	32.76M
March 31, 2016	31.95M
December 31, 2015	32.37M
September 30, 2015	29.83M
June 30, 2015	13.08M
March 31, 2015	0.00
December 31, 2014	0.00
September 30, 2014	0.00
June 30, 2014	0.00
March 31, 2014	16.24M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

-72.77M

Minimum

Dec 2019

103.02M

Maximum

Jun 2019

62.17M

Average

58.96M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks